IRIS Institutional Research Information System - OPENBS Open Archive UniBS

PRESTA, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 29.250
EU - Europa 12.632
AS - Asia 11.940
SA - Sud America 2.038
Continente sconosciuto - Info sul continente non disponibili 783
AF - Africa 325
OC - Oceania 78
Totale 57.046
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 28.572
CN - Cina 4.263
PL - Polonia 3.958
SG - Singapore 3.749
UA - Ucraina 2.113
BR - Brasile 1.646
DE - Germania 1.506
IT - Italia 1.482
HK - Hong Kong 1.268
VN - Vietnam 811
FI - Finlandia 796
GB - Regno Unito 699
FR - Francia 563
RU - Federazione Russa 438
IN - India 410
TR - Turchia 408
IE - Irlanda 373
BD - Bangladesh 320
CA - Canada 306
AR - Argentina 120
SE - Svezia 120
MX - Messico 115
ZA - Sudafrica 112
NL - Olanda 105
CZ - Repubblica Ceca 102
ES - Italia 102
ID - Indonesia 101
JP - Giappone 98
IQ - Iraq 77
EC - Ecuador 76
AU - Australia 69
CO - Colombia 58
PK - Pakistan 55
JM - Giamaica 47
MA - Marocco 47
VE - Venezuela 46
AT - Austria 45
IR - Iran 43
BE - Belgio 42
SA - Arabia Saudita 40
IL - Israele 37
CL - Cile 34
CR - Costa Rica 32
KE - Kenya 30
NG - Nigeria 26
UZ - Uzbekistan 26
LT - Lituania 25
TT - Trinidad e Tobago 25
CH - Svizzera 24
PE - Perù 22
AZ - Azerbaigian 20
HN - Honduras 20
MU - Mauritius 20
MY - Malesia 20
EU - Europa 19
JO - Giordania 19
SV - El Salvador 19
AE - Emirati Arabi Uniti 18
EE - Estonia 18
NI - Nicaragua 18
PH - Filippine 18
TH - Thailandia 18
GT - Guatemala 17
PY - Paraguay 17
EG - Egitto 16
KR - Corea 16
KZ - Kazakistan 16
TN - Tunisia 16
DZ - Algeria 14
GP - Guadalupe 14
PA - Panama 14
BG - Bulgaria 13
RO - Romania 13
CW - ???statistics.table.value.countryCode.CW??? 11
NO - Norvegia 11
NP - Nepal 11
HU - Ungheria 10
PR - Porto Rico 10
TW - Taiwan 10
ET - Etiopia 9
GR - Grecia 9
KG - Kirghizistan 9
SC - Seychelles 9
UY - Uruguay 9
BO - Bolivia 8
CU - Cuba 8
DK - Danimarca 8
DO - Repubblica Dominicana 8
GE - Georgia 8
LK - Sri Lanka 8
LV - Lettonia 8
PT - Portogallo 8
HR - Croazia 7
LB - Libano 7
OM - Oman 7
SK - Slovacchia (Repubblica Slovacca) 7
SN - Senegal 7
AL - Albania 6
BS - Bahamas 6
NZ - Nuova Zelanda 6
Totale 56.200
Salva come PNG Salva come JPEG
Città #
Warsaw 3.948
Fairfield 3.027
Ashburn 2.657
Woodbridge 2.189
Singapore 1.984
Jacksonville 1.583
San Jose 1.565
Houston 1.525
Hong Kong 1.254
Ann Arbor 1.180
Cambridge 1.175
Seattle 1.110
Wilmington 1.063
Beijing 922
Chandler 798
Council Bluffs 792
The Dalles 736
Princeton 671
Nanjing 581
New York 544
Los Angeles 475
Helsinki 438
Brescia 395
Dublin 370
Dallas 366
Dearborn 337
Istanbul 307
Lauterbourg 303
Columbus 298
Ho Chi Minh City 225
Munich 223
Santa Clara 216
Dong Ket 181
San Francisco 181
Nanchang 180
São Paulo 178
Buffalo 175
Milan 172
Moscow 160
Chicago 153
Des Moines 152
Shenyang 151
Jinan 145
Hebei 144
San Diego 141
Changsha 139
Shanghai 138
Hanoi 126
Phoenix 118
Orem 114
Lancaster 108
Tianjin 106
London 103
Jiaxing 101
Redondo Beach 97
Boardman 94
Tokyo 89
North Bergen 84
Brooklyn 80
Rome 75
Kunming 73
Turku 69
Jakarta 67
Montreal 67
Hangzhou 66
Chennai 65
Brno 64
Atlanta 62
San Mateo 61
Guangzhou 60
Toronto 58
Johannesburg 57
Madrid 55
Verona 55
Boston 54
Porto Alegre 51
Denver 49
Haikou 48
Augusta 47
Amsterdam 46
Rio de Janeiro 46
Zhengzhou 45
Ningbo 44
Stockholm 44
Lanzhou 42
Nuremberg 42
Manchester 40
Mexico City 40
Charlotte 38
Belo Horizonte 36
Brussels 35
Frankfurt am Main 35
Kocaeli 35
Washington 35
Poplar 34
Brasília 33
Leawood 33
Curitiba 30
Mumbai 30
Dhaka 29
Totale 38.862
Salva come PNG Salva come JPEG
Nome #
Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. 419
Brain angioarchitecture and intussusceptive microvascular growth in a murine model of Krabbe disease 409
Bone morphogenic protein antagonist Drm/gremlin is a novel proangiogenic factor. 382
Long Pentraxin-3 inhibits FGF-dependent angiogenesis andgrowth of steroid hormone-regulated tumors 370
The nanostructured secretome 369
U94 of human herpesvirus 6 down-modulates Src, promotes a partial mesenchymal-to-epithelial transition and inhibits tumor cell growth, invasion and metastasis 355
alphavbeta3 Integrin-dependent antiangiogenic activity of resveratrol stereoisomers. 336
Antiangiogenic activity of semisynthetic biotechnological heparins: low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonists. 333
Nanoliter contact angle probes tumor angiogenic ligand-receptor protein interactions 320
Blocking the FGF/FGFR system as a "two-compartment" antiangiogenic/antitumor approach in cancer therapy. 318
Fibroblast growth factor 2-antagonist activity of a long-pentraxin 3-derived antiangiogenic pentapeptide. 317
A long pentraxin-3-derived pentapeptide for the therapy of FGF8b-driven steroid hormone-regulated cancers 314
Gremlin is a novel agonist of the major pro-angiogenic receptor VEGFR2 311
Cutting edge: extracellular high mobility group box-1 protein is a proangiogenic cytokine. 309
Claudin3 is localized outside the tight junctions in human carcinomas 307
Fibroblast growth factor modulates mast cell recruitment in a murine model of prostate cancer 306
Synthesis, Structural Elucidation, and Biological Evaluation of NSC12, an Orally Available Fibroblast Growth Factor (FGF) Ligand Trap for the Treatment of FGF-Dependent Lung Tumors 304
Different effects of mucosal, beef lung, and chemically modified heparin on selected biological properties of basic fibroblast growth factor 301
Anti-angiogenic activity of the flavonoid precursor 4-hydroxychalcone. 300
The COOH-Terminal Peptide of Platelet Factor-4 Variant (CXCL4L1/PF-4var47-70) Strongly Inhibits Angiogenesis and Suppresses B16 Melanoma Growth In vivo. 297
Heparan Sulfate Proteoglycans Mediate the Angiogenic Activity of the Vascular Endothelial Growth Factor Receptor-2 Agonist Gremlin. 295
Interaction of fibroblast growth factor-2 (FGF-2) with free gangliosides: biochemical characterization and biological consequences in endothelial cell cultures. 295
Angiogenic growth factors interactome and drug discovery: The contribution of surface plasmon resonance 294
The broad-spectrum anti-DNA virus agent cidofovir inhibits lung metastasis of virus-independent, FGF2-driven tumors. 294
Ruolo dell’eparina e dei proteoglicani eparan solfati nella modulazione dell’angiogenesi indotta dal fattore di crescita basico dei fibroblasti 290
Angiopoietin-1 mediates the pro-angiogenic activity of the bone morphogenic protein antagonist Drm 289
Sphingosine-1-phosphate receptor-1 controls venous endothelial barrier integrity in zebrafish. 286
Monomeric gremlin is a novel vascular endothelial growth factor receptor-2 antagonist 285
Chemically sulfated Escherichia coli K5 polysaccharide derivatives as extracellular HIV-1 Tat protein antagonists. 284
β3 Integrin promotes long-lasting activation and polarization of vascular endothelial growth factor receptor 2 by immobilized ligand 280
Matrigel plug assay: evaluation of the angiogenic response by reverse transcription-quantitative PCR 273
Mammalian tumor xenografts induce neovascularization in zebrafish embryos. 268
Involvement of α(v)β (3) integrin in gremlin-induced angiogenesis. 268
TR-644 a novel potent tubulin binding agent induces impairment of endothelial cells function and inhibits angiogenesis. 266
Modulation of angiogenesis by a tetrameric tripeptide that antagonizes vascular endothelial growth factor receptor 1 266
Role of the soluble pattern recognition receptor PTX3 in vascular biology. 260
The pattern recognition receptor PTX3 as an angiostatic epithelial/stromal FGF-targeting inhibitor in hormonal cancers 258
Zebrafish disease models in hematology: Highlights on biological and translational impact 253
Fibroblast growth factors/fibroblast growth factor receptors as targets for the development of anti-angiogenesis strategies. 252
Cyclic adenosine monophosphate-response element-binding protein mediates the proangiogenic or proinflammatory activity of gremlin. 245
A Pro-inflammatory Signature Mediates FGF2-induced Angiogenesis 241
Anti-FGF2 approaches as a strategy to compensate resistance to anti-VEGF therapy: long-pentraxin 3 as a novel antiangiogenic FGF2-antagonist. 236
Integrin {alpha}V{beta}3 as a Target for Blocking HIV-1 Tat-Induced Endothelial Cell Activation In Vitro and Angiogenesis In Vivo. 234
ANTI-ANGIOGENIC ACTIVITY OF A NEUTRALIZING HUMAN SINGLE-CHAIN ANTIBODY FRAGMENT AGAINST FIBROBLAST GROWTH FACTOR RECEPTOR 1 231
Long pentraxin-3 follows and modulates bladder cancer progression 231
d-Peptide analogues of Boc-Phe-Leu-Phe-Leu-Phe-COOH induce neovascularization via endothelial N-formyl peptide receptor 3 229
Long Pentraxin 3/TSG-6 Interaction: A Biological Rheostat for Fibroblast Growth Factor 2–Mediated Angiogenesis 228
Nerve growth factor-endothelial cell interaction leads to angiogenesis in vitro and in vivo. 226
Fibroblast growth factor receptor-1 phosphorylation requirement for cardiomyocyte differentiation in murine embryonic stem cells. 224
Biological activity of substrate-bound basic fibroblast growth factor (FGF2): recruitment of FGF receptor-1 in endothelial cell adhesion contacts. 223
A tool for the quantification of radial neo-vessels in chick chorioallantoic membrane angiogenic assays 223
Anti-angiogenic activity of the purine analog 6-thioguanine. 222
Fibroblast growth factor-2 antagonist and Antiangiogenic activity of long-pentraxin 3-derived synthetic peptides 220
Basic fibroblast growth factor in neuronal cultures of human fetal brain. 219
A Pro-inflammatory Signature Mediates FGF2-induced Angiogenesis 217
Antiangiogenic effectiveness of the urokinase receptor- derived peptide UPARANT in a model of oxygen-induced retinopathy 217
Long Pentraxin-3 As An Epithelial-Stromal Fibroblast Growth Factor-Targeting Inhibitor In Prostate Cancer. 217
A distinct basic fibroblast growth factor (FGF-2/FGF receptor interaction distinguishes urokinase-type plasminogen activator induction from mitogenicity in endothelial cells 215
Paracrine and autocrine effects of fibroblast growth factor-4 in endothelial cells. 215
The zebrafish/tumor xenograft angiogenesis assay. 212
Long pentraxin-3 inhibits epithelial-mesenchymal transition in melanoma cells. 212
Basic fibroblast growth factor-induced angiogenic phenotype in mouse endothelium. A study of aortic and microvascular endothelial cell lines. 211
Stromal delivery of long Pentraxin-3 impairs FGF/FGFR-dependent tumor growth and metastasis 210
Critical role of gonadal hormones on the genotoxic activity of the hepatocarcinogen DL-ZAMI 1305. 209
CEACAM1/VEGF cross-talk during neuroblastic tumour differentiation 206
A novel pro-oncogenic mutated form of VEGFR2 modulates the activity of co-expressed wild-type receptor in melanoma 205
Age-dependent, seasonal and daily variations of the DNA damaging capacity of the hepatocarcinogen ZAMI 1305 in female rat liver. 203
alphav/beta3 Integrin mediates the cell-adhesive capacity and biological activity of basic fibroblast growth factor (FGF2) in cultured endothelial cells 202
Biologically active synthetic fragments of human basic fibroblast growth factor (bFGF): identification of two Asp-Gly-Arg-containing domains involved in the mitogenic activity of bFGF in endothelial cells. 202
Molecular cloning and knockdown of galactocerebrosidase in zebrafish: New insights into the pathogenesis of Krabbe's disease. 199
The potential of fibroblast growth factor/fibroblast growth factor receptor signaling as a therapeutic target in tumor angiogenesis. 199
3D endothelial cell spheroid/human vitreous humor assay for the characterization of anti-angiogenic inhibitors for the treatment of proliferative diabetic retinopathy 199
Long Pentraxin 3-Mediated Fibroblast Growth Factor Trapping Impairs Fibrosarcoma Growth 199
Shedding of membrane vesicles mediates fibroblast growth factor-2 release from cells. 198
Ascorbic acid rescues cardiomyocyte development in Fgfr1(-/-) murine embryonic stem cells. 198
Contribution of vascular endothelial growth factor receptor-2 sialylation to the process of angiogenesis 198
Long-Pentraxin 3 Derivative as a Small-Molecule FGF Trap for Cancer Therapy 198
ANGIOPOIETIN-1 MEDIATES THE PRO-ANGIOGENIC ACTIVITY OF THE BONE MORPHOGENIC PROTEIN ANTAGONIST DRM 196
Basic fibroblast growth factor requires a long-lasting activation of protein kinase C to induce cell proliferation in transformed fetal bovine aortic endothelial cells. 194
Ascorbic acid rescues cardiomyocyte development in Fgfr1-/- murineembryonic stem cells 194
Basic fibroblast growth factor is released from endothelial extracellular matrix in a biologically active form. 193
Atypical chemokine receptor 3 generates guidance cues for CXCL12-mediated endothelial cell migration 193
Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis. 192
ANGIOPOIETIN-1 MEDIATES THE PRO-ANGIOGENIC ACTIVITY OF THE BONE-MORPHOGENIC PROTEIN ANTAGONIST DRM 192
Fibroblast growth factors (FGFs) in cancer: FGF traps as a new therapeutic approach 190
Alterations of blood vessel development by endothelial cells overexpressing fibroblast growth factor-2 189
The thymidine phosphorylase inhibitor 5'-O-tritylinosine (KIN59) is an anti-angiogenic multi-target fibroblast growth factor-2 antagonist. 189
Total reflection X-Ray fluorescence spectroscopy to study Pb and Zn accumulation in zebrafish embryos 189
Role of Nanomechanics in Canonical and Noncanonical Pro-angiogenic Ligand/VEGF Receptor-2 Activation 187
Beta-Galactosylceramidase deficiency: neurovascular implications 185
Delivering cytokines at tumor site: The immunocytokine-conjugated anti-EDB-fibronectin antibody case 184
A six-amino acid deletion in basic fibroblast growth factor dissociates its mitogenic activity from its plasminogen activator-inducing capacity. 184
Examining new models for the study of autocrine and paracrine mechanisms of angiogenesis through FGF2-transfected endothelial and tumour cells. 184
Calcitonin receptor-like receptor guides arterial differentiation in zebrafish. 183
Zebrafish (Danio rerio) embryo as a platform for the identification of novel angiogenesis inhibitors of retinal vascular diseases 183
Human vitreous in proliferative diabetic retinopathy: Characterization and translational implications 182
Antiangiogenic and vascular-targeting activity of the microtubule-destabilizing trans-resveratrol derivative 3,5,4'-trimethoxystilbene. 181
Gene expression profile in fibroblast growth factor 2-transformed endothelial cells. 181
Inflammation and N-formyl peptide receptors mediate the angiogenic activity of human vitreous humour in proliferative diabetic retinopathy 179
Dendritic cells in inflammatory angiogenesis and lymphangiogenesis 179
Totale 24.409
Salva come PNG Salva come JPEG
Categoria #
all - tutte 249.496
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 249.496
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.137 0 0 0 78 41 137 191 182 150 430 232 696
2022/20232.386 417 113 114 138 178 627 17 188 315 37 112 130
2023/20242.949 186 98 337 117 124 466 123 127 680 127 58 506
2024/20256.143 86 57 40 861 652 574 516 250 708 468 1.139 792
2025/202613.407 1.327 1.675 1.078 1.838 1.441 883 2.044 444 792 1.113 538 234
2026/20274.097 597 763 1.013 1.724 0 0 0 0 0 0 0 0
Totale 57.046